Matthew Herper says: The weak dollar strikes again, as another U.S.-based biotech gets bought by an overseas drugmaker. Ipsen already owned 25% of Tercica, which makes a hormone for treating children who are not growing adequately. Still, that 104% premium is pretty eye-catching. |
View the Top Clips from June 4, 2008
Embed This Clip In Your Site...
|
||||||||||
|
|
|||||||||||
|
New from the makers of Clipmarks: Amplify.com - Don't just share the news...Amplify it!
|
|||||||||||